Publications by Center Staff

2001

Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS and Selkoe, DJ (2001). Ubiquitination of a new form of alpha-synuclein by parkin from human brain:  implications for parkinson’s disease. Science; 293: 263-269.

2001

Newell KL, Silver MH, Perls TT and Hedley-Whyte ET (2001). What centenarians teach us about neuropathology. Envejecimiento cerebral y enfermedad. JM Martinez Lage and V Hachinski (Eds.). Madrid, Spain, Editorial Triacastela:  31-46.

2000

Goldstein LE, Hartshorn M, Leopold MC, Huang X, Atwood CS, Saunders AJ, Lim J, Faget K, Scarpa RC, Chylack PT, Bowden EF, Tanzi RE and Bush AI (2000). 3-hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin crosslinking by metal ion reduction. Biochem; 39: 7266-7275.

2000

Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfield S and Ding C (2000). A 5-month, randomized, placebo controlled, trial of galantamine in ad. Neurol; 54: 2269-2276.

2000

Mitchell SL, Berkowitz RE, Lawson FME and Lipsitz LA (2000). A cross-national survey of tube-feeding decisions in cognitively impaired older persons. J Am Geriatrics Soc: 48: 391-397.

2000

Fezoui Y, Hartley DM, Walsh DM, Selkoe DJ, Osterhout JJ and Teplow DB (2000). A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nature Structural Biology; 7: 1095-1099.

2000

Gómez-Tortosa E, Newell K, Irizarry MC, Sanders JL and Hyman, BT (2000). Alpha-synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathologica; 99:  352-357.

2000

Fezoui Y, Hartley DM, Harper JD, Khurana R, Walsh DM, Condron MM, Selkoe DJ, Lansbury Jr PT, Fink AL and Teplow DB (2000). An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments. Amyloid: Int J Exp Clin Invest; 7: 166-178.

2000

Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Hsiao Ashe K, Irizarry M and Hyman BT (2000).  Apoe facilitates neuritic and vascular plaque formation in an alzheimer’s disease model.  Ann Neurol; 47: 739-747.

2000

Irizarry MC, Cheung BS, Rebeck GW, Paul SM, Bales KR, and Hyman BT (2000).  Apolipoprotein-e affects the amount form, and anatomical distribution of abeta-deposition in homozygous appv717f transgenic mice.  Acta Neuropathol; 100: 451-458.